Causes and Treatments of Merkel Cell Carcinoma

Merkel Cell Carcinoma (MCC) is an aggressive and rare form of skin cancer that originates from Merkel cells. These cells are located in the top layer of the skin and are responsible for the sense of touch. The malignancy is notable for its rapid growth and potential for metastasis, making early diagnosis and treatment crucial.

---

Causes of Merkel Cell Carcinoma

The exact etiology of Merkel Cell Carcinoma is not entirely understood, but several factors have been identified that contribute to its development. One prominent cause is the Merkel cell polyomavirus (MCV), which is found in approximately 80% of MCC cases. This virus is believed to integrate into the DNA of Merkel cells, leading to mutations that result in uncontrolled cell growth.

Another significant cause is ultraviolet (UV) radiation exposure. Prolonged exposure to UV rays from the sun or tanning beds can damage the DNA in skin cells, increasing the likelihood of developing MCC. Additionally, immune suppression, whether due to medical conditions like HIV/AIDS or immunosuppressive drugs used after organ transplants, can elevate the risk of Merkel Cell Carcinoma.

---

Symptoms of Merkel Cell Carcinoma

Initial Signs

Merkel Cell Carcinoma often presents as a painless, firm, red or violet nodule on sun-exposed areas of the skin, such as the face, neck, arms, and legs. These nodules can grow rapidly, sometimes doubling in size within a few weeks.

Advanced Symptoms

As the malignancy progresses, it may spread to nearby lymph nodes and other parts of the body, including the liver, lungs, bones, and brain. Depending on the location of metastasis, this dissemination can lead to more severe symptoms such as fatigue, unexplained weight loss, and organ dysfunction.

---

Risk Factors for Merkel Cell Carcinoma

Age and Gender

MCC predominantly affects older adults, with the majority of cases occurring in individuals over 50 years of age. Additionally, men are more likely to develop Merkel Cell Carcinoma than women.

Skin Type and Sun Exposure

Individuals with fair skin, light hair, and light-coloured eyes are at a higher risk for MCC due to their increased susceptibility to UV radiation damage. A history of extensive sun exposure or the use of tanning beds further amplifies this risk.

Immune Suppression

A compromised immune system can significantly increase the risk of MCC. Conditions such as HIV/AIDS, chronic lymphocytic leukemia (CLL), and the use of immunosuppressive medications post-organ transplantation are notable risk factors.

---

Diagnosis of Merkel Cell Carcinoma

Physical Examination and Biopsy

Diagnosis begins with a thorough physical examination of the skin and lymph nodes. If a suspicious lesion is identified, a biopsy is performed to obtain a tissue sample. This sample is then examined under a microscope to confirm the presence of Merkel cell carcinoma cells.

Imaging Studies

To determine the extent of the disease, imaging studies such as computed tomography (CT) scans, magnetic resonance imaging (MRI), and positron emission tomography (PET) scans may be employed. These imaging modalities help in assessing the spread of the cancer to lymph nodes and other organs.

Sentinel Lymph Node Biopsy

A sentinel lymph node biopsy is often conducted to evaluate the involvement of nearby lymph nodes. This procedure involves injecting a radioactive substance near the tumour site and identifying the first lymph node (sentinel node) that drains the area. The sentinel node is then surgically removed and examined for cancer cells.

---

Staging of Merkel Cell Carcinoma

Staging is a critical aspect in the management of MCC, as it determines the extent of the disease and guides treatment decisions. The American Joint Committee on Cancer (AJCC) staging system for MCC includes the following stages:

Stage 0 (In Situ)

Cancer cells are confined to the outer layer of the skin and have not invaded deeper tissues.

Stage I

The tumour is 2 centimetres or smaller in diameter and has not spread to lymph nodes or distant sites.

Stage II

The tumour is larger than 2 centimetres but still has not spread to lymph nodes or distant sites.

Stage III

The cancer has spread to nearby lymph nodes but not to distant sites.

Stage IV

The cancer has metastasized to distant organs, such as the liver, lungs, bones, or brain.

---

Treatment Options for Merkel Cell Carcinoma

Surgery

Surgical excision is often the first line of treatment for localized MCC. The goal is to remove the tumour along with a margin of healthy tissue to ensure complete excision. In cases where the cancer has spread to lymph nodes, a lymph node dissection may be performed.

Radiation Therapy

Radiation therapy is commonly used in conjunction with surgery, especially if there is a high risk of recurrence. It involves using high-energy rays to destroy cancer cells and shrink tumours. Radiation can also be employed as a primary treatment in patients who are not candidates for surgery.

Chemotherapy

Chemotherapy may be recommended for advanced stages of MCC or when the cancer has metastasized. It involves the use of drugs that target and kill rapidly dividing cancer cells. While chemotherapy can be effective, it is often associated with significant side effects.

Immunotherapy

Immunotherapy has emerged as a promising treatment for MCC, particularly for advanced or metastatic cases. Drugs such as pembrolizumab and nivolumab, which are immune checkpoint inhibitors, have shown efficacy in boosting the body's immune response to target and destroy cancer cells.

Clinical Trials

Participation in clinical trials may be an option for patients with MCC. Clinical trials contribute to the advancement of medical knowledge and the development of novel therapies, offering access to new and potentially effective treatments that are not yet widely available.

---

Complications of Merkel Cell Carcinoma

MCC can lead to several complications, mainly if not diagnosed and treated early. These complications include:

Local Recurrence

Even after treatment, MCC has a high risk of local recurrence, necessitating close follow-up and monitoring.

Metastasis

The aggressive nature of MCC means it can quickly spread to other parts of the body, leading to complications such as organ dysfunction and a significant decline in overall health.

Treatment Side Effects

The treatments for MCC, including surgery, radiation, and chemotherapy, can have side effects ranging from mild to severe. These may include pain, fatigue, nausea, and an increased risk of infections.

---

Conclusion

Merkel Cell Carcinoma is a rare but aggressive form of skin cancer that requires prompt and comprehensive treatment. Understanding the causes, risk factors, symptoms, and treatment options is essential for effective management. By staying informed and vigilant, patients and healthcare providers can work together to improve outcomes and quality of life for those affected by MCC.

For more information and support, consult with a healthcare professional specializing in oncology and consider reaching out to patient advocacy organizations dedicated to skin cancer awareness and research.